Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06739811 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

Study acronym: Phoenix CIP347
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 months later Dec 2026 → Sep 2027
See other at-risk trials from Medtronic MiniMed, Inc.

Record History

  1. Primary and study completion pushed from Dec 2026 to Sep 2027 Eligibility criteria expanded, about 22 words · Secondary endpoints: details revised at 1 of 2 entries · Site details revised at 8 of 11 sites Show 3 more changesShow less
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised at 8 of 11 sites
  2. Site details revised at 2 of 11 sitesv10
  3. Primary endpoint(s) modified Trial sites expanded: 6 → 11 locations · Eligibility criteria expanded, about 6 words · Secondary endpoints revised (2)v9 Show 3 more changesShow less
    • Trial sites expanded: 6 → 11 locations
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints revised (2)

    See this version in full on ClinicalTrials.gov ↗

  4. Sponsor changed: Medtronic Diabetes to Medtronic MiniMed, Inc. Study sites: 3 to 6 · Primary completion date: Jun 2026 to Dec 2026 · Completion date: Jan 2027 to Dec 2026v8 Show 3 more changesShow less
    • Study sites: 3 to 6
    • Primary completion date: Jun 2026 to Dec 2026
    • Completion date: Jan 2027 to Dec 2026

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Mar 26, 2025 to Mar 21, 2025 Site details revised at 1 of 3 sitesv7 Show 1 more changeShow less
    • Site details revised at 1 of 3 sites
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 2 to 3v6
  2. Study sites: 1 to 2v5
  3. Re-verified, no change to tracked fieldsv4
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2025 to Mar 26, 2025 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2025 to Mar 26, 2025
    • Site details revised
  5. Start date: Jan 2025 to Mar 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the clinical performance of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in adult patients with Type 1 diabetes mellitus that cannot be controlled with subcutaneous insulin therapy (including external pump), and presenting with frequent, otherwise unexplained severe hyper- and/or hypoglycemia.
Trial Details
NCT Number NCT06739811
Lead Sponsor Medtronic MiniMed, Inc.
Conditions Type I Diabetes
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov